The preliminary clinical studies of using autologous platelet-rich plasma combined with amniotic membrane in ocular surface disease treatment

Li Lin,Fengjuan Gu,Qi Zhang,Min Zhao
DOI: https://doi.org/10.3760/cma.j.issn.1006-4443.2016.03.020
2016-01-01
Abstract:Objective To observe how autologous platelet-rich plasma combined with amniotic membrane may be used in treatment of refractory ocular surface disease,and to evaluate its clinical value and significance.Methods Thirty-three patients (43 eyes) in our hospital were treated with autologous platelet-rich plasma combined with amniotic membrane transplantation.As follow-up for one to six months,the patients were observed for their ocular surfaces repair and the improvement of symptoms.Results The ocular surface epitheliums of patients repaired by varied degrees,and patients themselves felt their symptoms were relieved in varied levels,18 cases (23 eyes) of chemical burns and thermal bums in 19 cases (24 eyes) of ocular surface epithelial basic repair,1 case of patients with corneal perforation.5 patients (10 eyes) with severe dry eye symptoms were improved consciously,the ocular surface epitheliums repaired partial or fully.Five eyes of 9 patients 9 eyes with corneal ulcer healing,3 cases improved significantly,1 case showed no change.Conclusions Autologous Platelet-Rich Plasma combined with amniotic membrane is a new type of amniotic membrane complex,which open up a new effective way of the ocular surface disease treatment.
What problem does this paper attempt to address?